Only half of Brits will get COVID-19 vaccine

Henrietta Strickland
August 10, 2020

Overall, only half of the population said that they would be certain or very likely to get a vaccine if one became available.

The damning figures come from a joint study by King's College London and Ipsos Mori, based on 2,237 interviews with United Kingdom residents aged 16-75.

The study found that people were more likely to reject the vaccine due to their attitudes and beliefs about science and authority, rather than reasons related to coronavirus itself.

The study found that just one in five (20%) will be fairly likely to have a coronavirus vaccine if one becomes available. That is one in six Brits.

A survey of the United Kingdom population found that while only 11 per cent of people between 55 and 75 would likely or definitely refuse to get the vaccine, this rose to 22 per cent of under 25s.

Those who said they would not get vaccinated included 34% who believed the government was using coronavirus to control the population, and 36% thought too much fuss was being made over the pandemic.

People who are comfortable with lockdown restrictions easing and who have not found the outbreak stressful were also more likely to say no to a vaccine.

The proportion of 16-24s (22%) and 25-34s (22%) who definitely will not or are unlikely to do so was twice as high as 55-75s (11%).

Professor Bobby Duffy, director of the Policy Institute at King's College London, said the study revealed that the government would need to conduct a nuanced campaign to tackle misinformation.

Moderna is charging $37 a dose for its experimental vaccine, which is far more than what other companies say they plan to charge for their vaccines, CBS News reported Wednesday.

Where people get information about the virus was also a factor, with 27% of people who get their news from WhatsApp claiming they would be unlikely to get a vaccine.

The Swiss federal government says it has struck a deal with Moderna to supply Switzerland with 4.5 million doses of a COVID-19 vaccine if the US biotech firm successfully develops one.

Antibodies can disable the coronavirus, while T-cells, a type of white blood cell, help to co-ordinate the immune system by targeting infected cells.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER